- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Virpax Pharmaceuticals (NASDAQ:VRPX), Quotes and News Summary
Virpax Pharmaceuticals (NASDAQ: VRPX)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-09 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | ||||||
| REV | 0 |
Virpax Pharmaceuticals Questions & Answers
You can purchase shares of Virpax Pharmaceuticals (NASDAQ: VRPX) through any online brokerage.
Other companies in Virpax Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Dermata Therapeutics (NASDAQ:DRMA), Onconova Therapeutics (NASDAQ:ONTX) and Universe Pharmaceuticals (NASDAQ:UPC).
There is no analysis for Virpax Pharmaceuticals
The stock price for Virpax Pharmaceuticals (NASDAQ: VRPX) is $1.3 last updated May 23, 2022, 8:00 PM UTC.
There are no upcoming dividends for Virpax Pharmaceuticals.
Virpax Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Virpax Pharmaceuticals.
Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.